文献速递细菌感染、耐药与抗菌药物新发突发、热带与寄生虫病

厌氧菌菌血症与结直肠癌的关联:一项基于人群的队列研究

Bacteremia With Anaerobic Bacteria and Association With Colorectal Cancer: A Population-based Cohort Study.
PubMed 文献 · Clin Infect Dis · 2022-01-01

在丹麦南部和西兰岛约200万人口中纳入45 774例菌血症发作和231 387例血培养阴性病例的基于人群的队列研究显示,牛链球菌群、败毒梭菌及多个特定肠道厌氧菌属菌血症与结直肠癌诊断风险升高相关,提示需进行结直肠检查。

要点

  • 牛链球菌群菌血症后一年内结直肠癌诊断风险为4.3%(HR 8.46,95%CI 3.51-20.4)。
  • 败毒梭菌菌血症后一年内结直肠癌诊断风险为20.8%(HR 76.2,95%CI 42.0-138)。
  • 多个特定肠道厌氧菌菌血症也与结直肠癌诊断风险升高相关,提示需结直肠检查。

核心结论

  • 特定肠道厌氧菌菌血症与结直肠癌诊断高风险相关,提示需进行结直肠检查。
  • 该策略可能还有助于发现腺瘤或其他癌前病变,但这些病变未纳入本研究。

研究设计与样本

  • 在丹麦南部和西兰岛开展基于人群的队列研究,研究人群约200万人。
  • 纳入2007年至2016年的45 774例菌血症发作和231 387例血培养阴性病例。
  • 菌血症发作数据与丹麦结直肠癌中央登记处数据联合分析。
  • 采用Cox回归分析计算风险比(HR)和95%置信区间(CI)。

主要发现

  • 牛链球菌群菌血症后一年内结直肠癌诊断风险为4.3%(HR 8.46,95%CI 3.51-20.4)。
  • 败毒梭菌菌血症后一年内结直肠癌诊断风险为20.8%(HR 76.2,95%CI 42.0-138)。
  • 卵形拟杆菌菌血症后一年内结直肠癌诊断风险为6.7%(HR 20.3,95%CI 5.04-81.8)。
  • 均匀拟杆菌菌血症后一年内结直肠癌诊断风险为5.4%(HR 16.2,95%CI 4.02-65.7)。
  • 第三梭菌菌血症后一年内结直肠癌诊断风险为3.6%(HR 13.9,95%CI 1.96-99.4);梭杆菌属(不包括坏死梭杆菌)为3.0%(HR 8.51,95%CI 2.73-26.5);革兰阳性厌氧球菌为3.6%(HR 10.9,95%CI 4.50-26.3);血培养阴性患者为0.4%。

临床怎么用

  • 作者认为,特定肠道厌氧菌菌血症与结直肠癌诊断高风险相关,提示需进行结直肠检查。
  • 作者认为,该策略可能还有助于发现腺瘤或其他癌前病变,但这些病变未纳入本研究。

局限性

  • 腺瘤或其他癌前病变未纳入本研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: There is a well-described association between bacteremia with bovis group streptococci or Clostridium septicum and an increased probability of a colorectal cancer (CRC) diagnosis. We wanted to investigate the existence of a similar association between CRC and bacteremia with other bacteria belonging to the gut microbiota.. METHODS: A population based cohort study in a population about 2 million people including 45 774 bacteremia episodes and 231 387 blood culture negative cases was performed in the Region of Southern Denmark and Region Zealand from 2007-2016. Episodes of bacteremia were combined with the Danish central register for CRC. We performed Cox's regression analysis with hazard ratios (HRs) and 95% confidence intervals (CIs). RESULTS: The study results confirmed previous findings of an increased risk of a CRC diagnosis after bacteremia with the bovis group streptococci (risk within a year: 4.3%; HR [95% CI]: 8.46 [3.51-20.4]) or C. septicum (20.8%; 76.2 [42.0-138]). Furthermore, Bacteroides ovatus (6.7%; 20.3 [5.04-81.8]), Bacteroides uniformis (5.4%; 16.2 [4.02-65.7]), Clostridium tertium (3.6 %; 13.9 [1.96-99.4]), Fusobacterium spp. (excluding F. necrophorum) (3.0 %; 8.51 [2.73-26.5]), and Gram-positive anaerobic cocci (3.6 %; 10.9 [4.50-26.3]) were also associated with an increased risk of a CRC diagnosis compared to patients with negative blood cultures (0.4%). CONCLUSIONS: Bacteremia with specific gut microbiota anaerobic bacteria is associated with a high risk of a diagnosis of CRC, indicating the need for colorectal workup. Importantly, this strategy also holds the possible additional benefit of detecting adenomas or other premalignant conditions, which were not included in the present study.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Justesen US, Nielsen SL, Jensen TG, et al. Bacteremia With Anaerobic Bacteria and Association With Colorectal Cancer: A Population-based Cohort Study. Clin Infect Dis. 2022. PMID: 35380653. doi:10.1093/cid/ciac259

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。